DOI: http://dx.doi.org/10.18203/2349-3933.ijam20205478

A study of the prevalence of hyperuricemia as well as its association with non-alcoholic fatty liver disease in three hundred patients at a tertiary care centre in North-East India

Anant Parasher, Padma Lahdol, Abhinav Aggarwal

Abstract


Background: Non-alcoholic fatty liver disease (NAFLD) is a condition defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. In recent years, an association between elevated serum uric acid concentrations and NAFLD has been reported. Thus, we intended to perform this cross-sectional study to establish the prevalence of hyperuricemia in NAFLD patients and its association with NAFLD in 300 patients at a tertiary care centre in North-East India.

Methods: In this hospital based cross-sectional study, 300 patients presenting in Assam medical college and hospital (AMCH) with diagnosed NAFLD were included during the one year period from July 2015 to June 2016.

Results: Hyperuricemia was observed in 99 cases out of a total of 300 cases of NAFLD (33%), and a statistically significant association was observed between the two parameters.

Conclusions: The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than that in those without hyperuricemia (78.19% versus 40.83%) (p<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (p<0.001).

 


Keywords


Cirrhosis, Hyperuricemia, Liver failure, Non-alcoholic fatty liver disease, Steatosis

Full Text:

PDF

References


LaBrecque D, Abbas Z, Anania F. World Gastroenterology Organisation. Global Guidelines. J Clin Gastroenterol. 2014:1.

Noureddin M, Loomba R. Non-alcoholic fatty liver disease: Indications for liver biopsy and non-invasive biomarkers. Clin Liver Dis (Hoboken). 2012;1(4):104-7.

Amarapurkar D, Hashimoto E, Lesmana L, Sollano J, Chen P, Goh K. How common is non-alcoholic fatty liver disease in the Asia Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22(6):788-93.

Angulo P. Non-alcoholic Fatty Liver Disease. New Engl J Med. 2002;346(16):1221-31.

Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2019;5.

Sheriff DTM. Obesity, Non Alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD). Endocrinol Metab Syn. 2011;1(S1).

Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of non-alcoholic fatty liver disease. Hepatology. 2010;52(1):79-104.

Wieckowska A, McCullough A, Feldstein A. Non-invasive diagnosis and monitoring of non-alcoholic steatohepatitis: Present and future. Hepatology. 2007;46(2):582-9.

Borra R. Non-alcoholic fatty liver disease in obesity and type 2 diabetes Studies using 1H MRS and PET. MEDICA - ODONTOLOGICA. SARJA - SER. D OSA - TOM. 862. 2009.

Seppälä-Lindroos A, Vehkavaara S, Häkkinen A, Goto T, Westerbacka J, Sovijärvi A, et al. Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men. J Clin Endocrinol Metab. 2002;87(7):3023-8.

Kojima S, Watanabe N, Numata M. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954-61.

Azharuddin M, Abdali N, Ajmal M, Ahmad I, Kamal A Non-alcoholic fatty liver disease, hyperuricemia and carotid intima-medial thickness: a case control study. Int J Contemp Med Res. 2016;3(9):2568-71.

Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav C. Prevalence of non-alcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016;60(1):26.

Kalra S, Vithalani M, Kulkarni C, Gulati G, Kadam Y, Pallivathukkal J, et al. Study of prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India. 2013;61(7):448-53.

Duseja A, Das A, Dhiman RK. Indian patients with non-alcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol. 2007;13:649-50.

Amarapurkar DN, Patel ND. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol. 2004;25:125-9.

Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2006;21(1):191-8.

Forlani G, Giorda C, Manti R, Mazzella N, De Cosmo S, Rossi M et al. The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes. J Diabetes Res. 2016;1-9.

Mhetre B, Honnutagi R, Patil S, Jugati A, Biradarpatil D, Biradar M. Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus. Int J Biomed Adv Res. 2016;7(2):97-101.

Sertoglu E, Ercin C, Celebi G, Gurel H, Kayadibi H, Genc H, et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem. 2014;47(6):383-8.

Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757-66.

Cai W, Wu X, Zhang B, Miao L, Sun Y, Zou Y, et al. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in north-western China. Arquivos Brasileiros de Endocrinologia & Metabologia. 2013;57(8):617-22.

Lee Y, Lee H, Lee J, Shin Y, Shim J. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med. 2010;48(2).

Afzali A, Weiss N, Boyko E, Ioannou G. Association between serum uric acid level and chronic liver disease in the United States. Hepatology. 2010;52(2):578-89.